Japanese Man Falls Unconscious After Taking ED Drug From China
This article was originally published in PharmAsia News
A Japanese man in Hiroshima fell unconscious after taking an erectile dysfunction drug made in China that has not been approved in Japan. The man, in his 30s, imported 24 capsules of Nangenzengzhangsu, and took the capsules once a day since the end of January. On Feb. 21, he fell unconsciousness at work and was rushed to the hospital. Two drug ingredients were found in the capsules, blood sugar lowering glibenclamide and sildenafil (the active ingredient in Pfizer's Viagra). The amount of glibenclamide contained in the capsules was found to greatly exceed the allowable level set forth in the Pharmaceutical Law. (Click for more-Japanese language
You may also be interested in...
A more conservative US Supreme Court may mean a less authoritative FDA, and drug pricing won’t get as much attention in the presidential campaign, which is a good thing.
The US HHS played defense on 20 September, pushing back on suggestions that secretary Alex Azar’s recent move to exert control over regulations by signing off on them was a power play aimed at the FDA. Meanwhile, former agency head Scott Gottlieb says it’s “the wrong move at the wrong time.”
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?